Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

The Bluegrass Vascular Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. 
News | EP Lab
Case Report on CRT Lead Placement in Obstructed Veins Using Surfacer System

May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of ...

Home May 06, 2021
Home
Videos | Cath Lab
VIDEO: Avoiding Higher Risk Cath Lab Patients May Not Improve Outcomes Scores

Ashwin Nathan M.D., a cardiology fellow in the division of Cardiovascular Medicine at the Hospital of the University of ...

Home May 05, 2021
Home
The Corindus CorPath robotic cath lab navigation system allows operators to sit and control the procedure from behind a lead-lined booth, so they do not have to wear heavy aprons during the procedures.  Christoper Baker, M.D., Hoag Memorial Hospital using the system. #SCAI21 #SCAI2021
Feature | Robotic Systems
Second Generation Robotic PCI System Performs Well Across Spectrum of Lesion Complexity

May 5, 2021 — A late-breaking study of the Siemens Healthineers Corindus Corpath GRX second-generation cath lab robotic ...

Home May 05, 2021
Home
Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.
News | Cardiovascular Business
Avoiding High-risk Cath Lab Procedures Does Not Necessarily Improve Hospital Scores

May 5, 2021 — A late-breaking study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 202 ...

Home May 05, 2021
Home
If MitraClip Fails 95 Percent of Patients Will Need Full Surgical Valve Replacement according to a late-breaking study at the AATS 2021 meeting. #AATS2021
News | Heart Valve Technology
If MitraClip Fails 95 Percent of Patients Will Need Surgical Valve Replacement

May 4, 2021 – A new study, presented at the 2021 American Association for Thoracic Surgery (AATS) 101st annual meeting ...

Home May 04, 2021
Home
One third of patients will die who have COVID-19 (SARS-CoV-2) and suffer a ST-elevated myocardial infarction (STEMI), according to the latest, comprehensive data from The North American COVID-19 Myocardial Infarction (NACMI) Registry. The data was presented as a late-breaking study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions. The study showed there was an alarming one-in-three patients dying with STEMI and COVID, compared to 4-in-100 #SCAI2021
Feature | Coronavirus (COVID-19) | By Dave Fornell, Editor
Third of COVID Patients With STEMI Heart Attacks Die

May 3, 2021 – One third of patients will die who have COVID-19 (SARS-CoV-2) and suffer a ST-elevated myocardial ...

Home May 03, 2021
Home
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images
News | Cath Lab
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria

May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for stable ...

Home May 03, 2021
Home
The NuMED 10-zig Covered CP (CCP) balloon expandable covered stent. It is used for repair of sinus venosus atrial septal defects (SVASD). #SVASD #SCAI2021 #congenitalheart #
News | Congenital Heart
Global registry Shows Longer Stent Minimizes Procedure Complications in Sinus Venosus Atrial Septal Defects

May 1, 2021 - An analysis of a new international registry reveals benefits of using a longer covered stent for ...

Home May 01, 2021
Home
Videos | Structural Heart
VIDEO: Socioeconomic and Geographic Access to TAVR Programs is Limited

Ashwin Nathan M.D., a cardiology fellow at the Hospital of the University of Pennsylvania, presented a late-breaking ...

Home April 30, 2021
Home
The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function. 
Feature | Structural Heart | Dave Fornell, Editor
One-year Results of the Harmony Transcatheter Pulmonary Valve Trial Presented at SCAI 2021 

April 30, 2021 — New study results validate the effectiveness of the Medtronic Harmony transcatheter pulmonary valve ...

Home April 30, 2021
Home
The two FDA-clear transcatheter aortic valve replacement (TAVR) valves on the market, the Edwards Lifesciences Sapien 3 (left) and the Medtronic CoreValve (right).
Feature | Structural Heart
TAVR Access is Inequitable Based Socioeconomics Level and Geography

April 30, 2021 – An analysis of growth patterns in transcatheter aortic valve replacement (TAVR) programs across United ...

Home April 30, 2021
Home
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab
Young African Americans With Coronary Disease Impacted by Non-traditional Risk Factors

April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American ...

Home April 29, 2021
Home
The Abiomed Impella percutaneous heart pump was shown in the NCSI study to greatly improve survival of acute myocardial infarction with cardiogenic shock (AMICS), raising survival from 50 percent to 71 percent. Ambulance image from Getty Images.
Feature | Cardiogenic Shock | By Dave Fornell, Editor
National Cardiogenic Shock Initiative Protocol Shows 71 Percent Survival 

April 29, 2021 — The results of a large, national heart attack study show that patients with  cardiogenic shock survived ...

Home April 29, 2021
Home
A Chinese registry study found there are higher event rates in patients with shorter dual-antiplatelet therapy (DAPT) after PCI procedures. There has been a lot of movement toward using shorter duration DAPT with newer generation drug-eluting stent technologies, but this study reinforces the need longer DAPT in many patients. The findings were presented as a late-breaking trial at SCAI 2021 today. 
News | Antiplatelet and Anticoagulation Therapies
Long-term Dual Antiplatelet Therapy Benefits Reinforced in SCAI Late-breaking Study

April 28, 2021 — An analysis of the prospective Chinese Fuwai PCI Registry, confirms long-term, dual-antiplatelet ...

Home April 28, 2021
Home
The STAT2 trial used a combination of the Biolife Statseal potassium ferrate hemostatic patch and a Terumo TR Band to reduce radial access arteriotomy site hemostasis by 50 percent.
News | Radial Access | Dave Fornell, Editor
Radial Hemostasis Time Cut by 50 Percent With StatSeal in Combination With TR Band

April 28, 2021 — A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to ...

Home April 28, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now